Antireflux stent versus conventional stent in the palliation of distal esophageal cancer. A randomized, multicenter clinical trial

References

• Rouvelas I, Zeng W, Lindblad M, Viklund P, Ye W, Lagergren J. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 2005;6:864–70.
   PubMed Web of Science ®Google Scholar
• Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993;329(18):1302–7.
   PubMedGoogle Scholar
• Wenger U, Luo J, Lundell L, Lagergren J. A nationwide study of the use of self-expanding stents in patients with esophageal cancer in Sweden. Endoscopy 2005;37(4):329–34.
   PubMedGoogle Scholar
• Wu WC, Katon RM, Saxon RR, Barton RE, Uchida BT, Keller FS, . Silicone-covered self-expanding metallic stents for the palliation of malignant esophageal obstruction and esophagorespiratory fistulas: experience in 32 patients and a review of the literature. Gastrointest Endosc 1994; 40(1):22–33.
   PubMedGoogle Scholar
• Homs MY, Wahab PJ, Kuipers EJ, Steyerberg EW, Grool TA, Haringsma J, . Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia:a randomized trial. Gastrointest Endosc 2004; 60(5):695–702.
   PubMedGoogle Scholar
• Nunes CC, Waechter FL, Sampaio JA, Pinto R, Aluares-Da-Silva MR, Pereira-Lima L. Comparative postoperative study of prostheses with an antireflux valve system in the palliative treatment of esophageal carcinoma. Hepatogastroenterology 1999;46(29):2859–64.
   PubMedGoogle Scholar
• Valbuena J. Endoscopic palliative treatment of esophageal and cardial cancer: a new antireflux prosthesis: a study of 40 cases. Cancer 1984;53(4):993–8.
   PubMedGoogle Scholar
• Dua K, Kozarek R, Kim J, Evans J, Medda B, Lang I, . Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc 2001;53(6):603–13.
   PubMedGoogle Scholar
• Power C, Byrne PJ, Lim K, Ravi N, Moore J, Fitzgerald T, . Superiority of anti-reflux stent compared with conventional stents in the palliative management of patients with cancer of the lower esophagus and esophago-gastric junction: results of a randomized clinical trial. Dis Esophagus 2007;20:466–70.
   PubMedGoogle Scholar
• Sabharwal T, Gulati MS, Fotiadis N, Dourado R, Botha A, Mason R, . Randomised comparison of the FerX Ella antireflux stent and the ultraflex stent: proton pump inhibitor combination for prevention of post-stent reflux in patients with esophageal carcinoma involving the esophago-gastric junction. J Gastroenterol Hepatol 2008;23:723–8.
   PubMedGoogle Scholar
• Schoppmeyer K, Golsong J, Schiefke I, Mossner J, Caca K. Antireflux stents for palliation of malignant esophagocardial stenosis. Dis Esophagus 2007;20:89–93.
   PubMedGoogle Scholar
• Shim CS, Jung IS, Cheon YK, Ryu CB, Hong SJ, Kim JO, . Management of malignant stricture of the esophagogastric juncton with a newly designed self-expanding metal stent with an antireflux mechanism. Endoscopy 2005;37:335–9.
   PubMed Web of Science ®Google Scholar
• Verschuur EM, Repici A, Kuipers EJ, Steyerberg EW, Siersema PD. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol 2008;103(2):304–12.
   PubMedGoogle Scholar
• Barbour AP, Lagergren P, Hughes R, Alderson D, Barham CP, Blazeby JM. Health-related quality of life among patients with adenocarcinoma of the gastro-esophageal junction treated by gastrectomy or esophagectomy. Br J Surg 2008;95(1):80–4.
   PubMedGoogle Scholar
• Blazeby JM, Avery K, Sprangers M, Pikhart H, Fayers P, Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006;24:3178–86.
   PubMed Web of Science ®Google Scholar
• Langenhoff BS, Krabbe PF, Wobbes T, Ruers TJ. Quality of life as an outcome measure in surgical oncology. Br J Surg 2001;88:643–52.
   PubMed Web of Science ®Google Scholar
• Wenger U, Johnsson E, Arnelo U, Lundell L, Lagergren J. An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study. Surg Endosc 2006;20(11):1675–80.
   PubMedGoogle Scholar
• Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, . The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365–76.
   PubMed Web of Science ®Google Scholar
• Fayers P, Aaronson N, Bjurdal K, Sullivan M, Curran D, Groenvold M. The EORTC QLQ-C 30 scoring manual. Brussels, Belgium: European Organisation for Research and Treatment of Cancer; 1999.
   Google Scholar
• Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, . Development of an EORTC questionnaire module to be used in quality-of-life assessment for patients with esophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer 1996;32A(11):1912–17.
   PubMedGoogle Scholar
• King MT. The interpretation of scores from the EORTC quality-of-life questionnaire QLQ-C30. Qual Life Res 1996;5(6):555–67.
   PubMedGoogle Scholar
• Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998;16(1):139–44.
   PubMedGoogle Scholar
• Shenfine J, McNamee P, Steen N, Bond J, Griffin SM. A pragmatic randomised controlled trial of the cost-effectiveness of palliative therapies for patients with inoperable oesophageal cancer. Health Technol Assess 2005;9(5):iii, 1–121.
   Google Scholar
• Viklund P, Lindblad M, Lagergren J. Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg 2005;29:841–8.
   PubMedGoogle Scholar
• Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut 2003;52:922–6.
   PubMed Web of Science ®Google Scholar
• Siersema PD, Hop WC, van Blankenstein M, van Tilburg AJ, Bac DJ, Homs MY, . A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc 2001;54:145–53.
   PubMed Web of Science ®Google Scholar
• Laasch HU, Marriott A, Wilbraham L, Tunnah S, England RE, Martin DF. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology 2002;225(2):359–65.
   PubMedGoogle Scholar